Locations:
November 12, 2026/News Releases

$20.2 Million Raised for VeloSano, Funding Cancer Research at Cleveland Clinic in 2026

A year of fundraising and generosity accelerates search for a cure through VeloSano, a Cleveland Clinic global fundraising movement to end cancer

Media Downloads

Content is property of Cleveland Clinic and for news media use only.

VeloSano riders

VeloSano raised $20.2 million in 2026 to fund cancer research at Cleveland Clinic

A total of $20.2 million was raised in 2026 for VeloSano, Cleveland Clinic's movement to fund lifesaving cancer research.

The total was announced today in a video celebrating the dedication of everyone's efforts throughout 2026. Since VeloSano began in 2014, more than $115 million has been raised for cancer research at Cleveland Clinic and Cleveland Clinic Children's. VeloSano began as a weekend event and has evolved into an initiative that engages individuals, families and organizations throughout the year.

This achievement was made possible through the collective efforts of the VeloSano community, including more than 5,000 participants and volunteers who supported Bike to Cure, Trike & Bike, Florida for the Cure and London for the Cure, as well as 30,000-plus donors who made direct contributions or legacy gifts to the VeloSano fund.

“Year after year, the VeloSano community demonstrates an extraordinary commitment to advancing cancer research,” said Alex A. Adjei, M.D., Ph.D., Chief of Cleveland Clinic Cancer Institute. “Every rider, donor, volunteer, sponsor and supporter has helped advance cancer research at Cleveland Clinic. While there is still much work ahead in the fight against cancer, this extraordinary support is enabling our researchers to pursue innovative discoveries, bring new treatments closer to patients and create hope for families around the world.”

Every dollar raised by VeloSano supports cancer research at Cleveland Clinic. A portion of VeloSano funds is awarded through a competitive application process known as VeloSano Pilot Grants. Since 2014, over 300 cancer research projects have been funded and an additional $107 million has been earned from extramural granting sources, making the total impact of VeloSano more than $222 million. Additionally, funding has supported clinical trials and the training of high school students, college students and postdoctoral fellows to ensure future generations continue the research to conquer cancer.

Bike to Cure weekend in September is one of the many events that contributes to VeloSano’s year-round fundraising effort. Nearly 2,650 riders and 800 volunteers participated in this year’s annual flagship event. In June, VeloSano Trike & Bike mobilized children ages 3 to 10 to ride around the Cleveland Metroparks Zoo and fundraise for pediatric cancer research. In June, Cleveland Clinic London participated in London for the Cure. 

VeloSano has been supported by long-time partners:

  • Founding Partners: the Cleveland Guardians and the Kohl Fund; 
  • Supporting Partners: Adcom, Jones Day, Lexus of Cleveland and Petitti Garden Centers;
  • Contributing Partners: Abbvie, Amgen, AstraZeneca, BeOne Medical, Bristol Myers Squibb, Genentech, Gilead, GSK, Incyte, Johnson & Johnson, KeyBank, The Lerner Foundation, Michelob Ultra, Novartis, Pfizer, Sanofi and TransDigm.

The next VeloSano Bike to Cure Weekend is Sept. 10-11, 2027. Registration opens on March 9, 2027, and additional information will be available in early 2027. To learn more about how to get involved, visit velosano.org/get-involved.

To read about projects funded by VeloSano visit impact.velosano.org.

About Cleveland Clinic

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation, Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 83,000 employees worldwide are more than 6,600 salaried physicians and researchers, and 21,900 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,725-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 300 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2025, there were 15.9 million outpatient encounters, 343,000 hospital admissions and observations, and 336,000 surgeries and procedures throughout Cleveland Clinic’s health system. Visit us at clevelandclinic.org. Follow us at x.com/CleClinicNews. News and resources are available at newsroom.clevelandclinic.org.

Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.

Latest from the Newsroom

Photo of spine imaging.

Cleveland Clinic Expands Orthopaedic Care in the Mahoning Valley Through Acquisition of Youngstown Orthopaedic Associates Practice

Lobby of new Toronto location

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Artist's rendering of gene therapy for high triglycerides.

Gene Editing Therapy Trial Dramatically Lowers Dangerous Blood Fat Levels

Artist's illustration of gene editing

Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective

Medical illustration of lipoprotein(a) molecule

Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years

Ali Aminian, M.D., performing bariatric surgery.

Cleveland Clinic Study Finds Bariatric Surgery Effective for Substantial Weight Loss After GLP-1 Intolerance or Limited Weight Loss

Eric Boose, M.D., uses AI software to document a patient appointment.

Newsweek Ranks Cleveland Clinic Among World's Best Smart Hospitals

Graphic representing cardiomyopathy and DNA

Cleveland Clinic-led Study Establishes Major Genetic Contributor to Heart Failure in People of African Ancestry